Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare part D exclusions

This article was originally published in The Tan Sheet

Executive Summary

"Medical foods such as enteral nutrients" are not regulated as drugs and therefore will not be covered by the Medicare Part D drug benefit, the Centers for Medicare & Medicaid Services says in a July 27 draft document. The prescription drug benefit, which allows Medicare recipients to receive drug coverage under the Medicare Modernization Act of 2003, becomes effective Jan. 1, 2006. In order to be included with the Part D benefit, a drug "generally must be regulated by the FDA as a drug, biological or vaccine," CMS explains. "Prescription vitamins and mineral products, except prenatal vitamins and fluoride preparations" may also be excluded from Part D coverage, according to the document. However, plan sponsors can "generally" include them as part of supplemental benefits...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098535

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel